CClinicalTrials.gg
Active, not recruitingNCT06874439EQUARUpdated Dec 4, 2025

An Evaluation of the WHO QUAlityRights Program

An interventional study of WHO QualityRights program in Recovery, Organization of Health Service and Mental Health Care, sponsored by GCS-CCOMS. Active, not recruiting at 10 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-12-04.

Sponsored by GCS-CCOMS · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Registered 8 months after the study started (first participant enrolled Jun 2024, registered Feb 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
1,800
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The World Health Organization's (WHO) QualityRights (QR) program offers assessments and recommendations to help mental health facilities, on a voluntary basis, improve their care practices towards better respect of the rights of service users. The aim of this study is to evaluate the QR program in a French national context.

The main questions it aims to answer are:

  • Does the QR program improve perceived satisfaction with care among mental health service users?
  • What are the implementation procedures of the program?
  • What is its budgetary impact?

Researchers will compare the QR program intervention with usual practices.

Read the detailed description

In France, despite the existence of recommendations and a restrictive legal framework, the use of restraint practices in psychiatry remains widespread, and the duration and conditions of hospitalization do not always guarantee respect for users' rights.

The World Health Organization's (WHO) QualityRights (QR) program offers assessments, called "observations", and recommendations to help mental health facilities, on a voluntary basis, improve their care practices towards better respect of the rights of service users. However, the program has never been evaluated in a French national context.

The WHO QR program, published in 2012 and regularly updated since, aims to improve the quality of care in mental health and related services and promote the rights of people with psychosocial, intellectual and cognitive disabilities.

The reference base for the tools that make up the program is the United Nations Convention on the Rights of Persons with Disabilities (CRPD), ratified by France in 2010. This international convention defines ambitious objectives in terms of respect for rights, some of which are particularly relevant to mental health services. However, the convention does not offer any concrete indications as to how these major international standards are to be applied.

The QR program provides a concrete response to this need, offering observation and training tools not only for mental health services, but more broadly for all those concerned by mental health issues. In particular, the observation methodology is designed to respond to a request for support in changing practices that comes directly from a facility.

The WHO Collaborating Centre in Lille is mandated by the WHO to roll out this program in France and other French-speaking countries. It is expected that the QualityRights approach will act as a lever for change in the organization of services, providing a multidisciplinary perspective on users' rights and recovery-oriented practices.

The primary research objective is to evaluate the effectiveness of the QR program on the perceived satisfaction with care of mental health service users.

The secondary research objectives concern:

A. Evaluating the effectiveness of the QR program on:

  1. Improving work-related quality of life among mental health professionals
  2. Decreasing the number of involuntary admissions
  3. Reducing the length of full-time hospital stays
  4. Reducing the number of acts of seclusion and restraint
  5. The distribution of clinical activity in favour of ambulatory activity

B. Evaluating the efficiency and the budgetary impact of the QR program.

C. Conducting an implementation study to understand the appropriation of the recommendations by professionals and management following the introduction of the QR program by exploring the representations linked to the QR program and respect for users' rights among mental health professionals.

This research involves an effectiveness study, supplemented by an implementation study based on a qualitative methodology, and an economic evaluation.

The effectiveness study is a cluster randomized trial designed to compare the effectiveness of the QR program intervention versus usual practices on user satisfaction. The cluster is defined at the level of the psychiatric sector (the public psychiatric care entity organizing the mental health care of a population within a pre-specified geographical and demographic area in France, to meet local needs). 10 psychiatric sectors are participating, randomized into two groups: the intervention group receiving the QR program and the control group maintaining their usual practices.

Data will be collected in both groups at baseline, and during follow-up at 1 and 2 years. The implementation study and the economic evaluation will be carried out in the intervention group after the effectiveness study.

02

Conditions studied

  • Recovery
  • Organization of Health Service
  • Mental Health Care
  • Mental Health Services

Keywords

  • User rights
  • Recovery-oriented practices
  • Mental Health Settings
  • Satisfaction with care
  • Interventional study
  • Randomized controlled trial
03

In context

Lead sponsor

GCS-CCOMS is the lead sponsor of 2 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Adults (18 years or older)
  • Persons having formulated a non-opposition to participate in the study
  • Population a (users): Service users of the psychiatric sectors involved in the study hospitalized full-time since at least 3 days in an inpatient unit.
  • Population b (professionals): Mental health professionals working in the sector since at least 3 months at the time of study participation

Exclusion criteria

Exclusion Criteria:

  • Persons physically or psychologically unable to participate at the time of the study
  • Persons subject to a safeguard of justice measure
  • Persons who do not speak or understand the French language
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
1,800 participants (estimated)

Study arms

  • Experimental
    Intervention

    Sectors receiving the WHO QualityRights program

    Other: WHO QualityRights program

  • No intervention
    Usual practices

    Sectors not receiving the WHO QualityRights program, and maintaining usual practices

Interventions

  • OtherWHO QualityRights program

    The WHO's QualityRights program involves an assessment, called observation, of mental health care services by an ephemeral multidisciplinary team, which provides feedback and recommendations for improving care practices. The observation team, trained in the QualityRights (QR) methodology, includes mental health professionals, researchers, legal experts, and management staff from mental health organizations. Each team always incorporates at least one expert by experience and one informal caregiver or family member. Participation in the program is voluntary and initiated at the request of healthcare facilities. The observation is structured into three stages: 1. Site preparation 2. On-site observation 3. Restitution of observation report and follow-up

06

What researchers measure

Primary outcomes

  1. Satisfaction with care

    Service user satisfaction with care score assessed using the Verona Service Satisfaction Scale (VSSS-54F)

    Time frame: At baseline, at 1 year, and at 2 years

Secondary outcomes

  1. Work-related quality of life

    Work-related quality of life score for mental health professionals assessed using the SERENAT scale

    Time frame: At baseline, at 1 year, and at 2 years

  2. Involuntary psychiatric hospitalisations

    Number of involuntary hospitalizations in the 6 months preceding the time point

    Time frame: At baseline, at 1 year, and at 2 years

  3. Length of stay

    Length of stay for each patient in the 6 months preceding the time points

    Time frame: At baseline, at 1 year, and at 2 years

  4. Seclusion and restraint

    Number of acts of seclusion and restraint in the 6 months preceding the time points

    Time frame: At baseline, at 1 year, and at 2 years

  5. Distribution of hospital activity

    Hospital case load and outpatient service utilization in the 6 months preceding the time points

    Time frame: At baseline, at 1 year, and at 2 years

  6. Cost-utility

    Incremental cost-utility ratio in cost per QALY gained (EQ-5D-5L questionnaire)

    Time frame: 24 months

  7. Cost-effectiveness

    Incremental cost-effectiveness ratio in cost per VSSS-54F score points gained

    Time frame: 24 months

  8. Budgetary impact - costs

    Costs associated with the generalization of the QR program

    Time frame: 5 years after hypothetical generalization

  9. Budgetary impact - QALY

    The number of QALYs will be calculated with and without the QR program to assess the gains associated with its generalization.

    Time frame: 5 years after hypothetical generalization

  10. Budgetary impact - Involuntary psychiatric hospitalizations

    The number of involuntary hospitalizations will be calculated with and without the QR program to assess the gains associated with its generalization.

    Time frame: 5 years after hypothetical generalization

  11. Budgetary impact - Length of stay

    The length of stay will be calculated with and without the QR program to assess the gains associated with its generalization.

    Time frame: 5 years after hypothetical generalization

  12. Budgetary impact - Seclusion and restraint

    The number of acts of seclusion and restraint will be calculated with and without the QR program to assess the gains associated with its generalization.

    Time frame: 5 years after hypothetical generalization

  13. Implementation

    Qualitative methods will be used through semi-structured interviews conducted with 10 mental health professionals per sector of the intervention group.

    Time frame: In the 1 year following the last time point

07

Study locations

10 sites
  • Public mental health establishment of Lille Metropole (59G09/G10)
    Armentières, 59280, France
  • Public mental health establishment of Lille Metropole (59G20)
    Armentières, 59280, France
  • Hospital Centre of Erstein
    Erstein, 67150, France
  • Psychotherapeutic Center of Nancy
    Laxou, 54520, France
  • Hospital Centre Drôme Vivarais
    Montéléger, 26760, France
  • Hospital Care Center of Nanterre
    Nanterre, 92014, France
  • Hospital Centre Sainte-Marie Nice
    Nice, 06100, France
  • Hospital Center of Plaisir (78G16)
    Plaisir, 78370, France
  • Hospital Center of Plaisir (78G18)
    Plaisir, 78370, France
  • Hospital Center of Candélie
    Pont-du-Casse, 47480, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 4, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06874439
Lead sponsor
GCS-CCOMS
Collaborators
INSERM ECEVE 1123, L'Assistance Publique - Hopitaux de Paris (AP-HP)
Responsible party
Sponsor
First posted
Mar 13, 2025
Start date
Jun 17, 2024
Primary completion
Jun 2027 (estimated)
Completion
Oct 2027 (estimated)
Last update
Dec 4, 2025

Study contacts

Déborah Sebbane, MD, PhD
study chair · GCS-CCOMS & ECEVE 1123 INSERM

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion